concentrix corp - CNXC

CNXC

Close Chg Chg %
43.88 -0.99 -2.26%

Closed Market

42.89

-0.99 (2.26%)

Volume: 626.43K

Last Updated:

Jan 7, 2026, 4:00 PM EDT

Company Overview: concentrix corp - CNXC

CNXC Key Data

Open

$43.87

Day Range

42.79 - 44.07

52 Week Range

31.63 - 66.00

Market Cap

$2.73B

Shares Outstanding

62.26M

Public Float

43.53M

Beta

0.48

Rev. Per Employee

N/A

P/E Ratio

9.01

EPS

$4.74

Yield

318.54%

Dividend

$0.36

EX-DIVIDEND DATE

Oct 24, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

887.52K

 

CNXC Performance

1 Week
 
5.53%
 
1 Month
 
16.67%
 
3 Months
 
-2.01%
 
1 Year
 
-4.09%
 
5 Years
 
-60.06%
 

CNXC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About concentrix corp - CNXC

Concentrix Corp. engages in the provision of customer experience solutions and technology. The company was founded in 1973 and is headquartered in Newark, CA.

CNXC At a Glance

Concentrix Corp.
39899 Balentine Drive
Newark, California 94560
Phone 1-800-747-0583 Revenue 9.62B
Industry Information Technology Services Net Income 241.71M
Sector Technology Services 2024 Sales Growth 35.202%
Fiscal Year-end 11 / 2025 Employees 450,000
View SEC Filings

CNXC Valuation

P/E Current 9.011
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 12.101
Price to Sales Ratio 0.304
Price to Book Ratio 0.715
Price to Cash Flow Ratio 4.38
Enterprise Value to EBITDA 5.528
Enterprise Value to Sales 0.841
Total Debt to Enterprise Value 0.692

CNXC Efficiency

Revenue/Employee 21,375.333
Income Per Employee 537.14
Receivables Turnover 4.992
Total Asset Turnover 0.786

CNXC Liquidity

Current Ratio 1.424
Quick Ratio 1.424
Cash Ratio 0.215

CNXC Profitability

Gross Margin 28.559
Operating Margin 7.881
Pretax Margin 3.111
Net Margin 2.513
Return on Assets 1.975
Return on Equity 5.908
Return on Total Capital 2.508
Return on Invested Capital 2.53

CNXC Capital Structure

Total Debt to Total Equity 138.558
Total Debt to Total Capital 58.082
Total Debt to Total Assets 46.678
Long-Term Debt to Equity 132.656
Long-Term Debt to Total Capital 55.607
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Concentrix Corp - CNXC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
5.59B 6.32B 7.11B 9.62B
Sales Growth
+18.38% +13.20% +12.49% +35.20%
Cost of Goods Sold (COGS) incl D&A
3.92B 4.35B 4.91B 6.87B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
277.18M 309.54M 388.30M 705.85M
Depreciation
140.24M 146.86M 173.46M 246.92M
Amortization of Intangibles
136.94M 162.67M 214.83M 458.93M
COGS Growth
+16.68% +11.05% +12.94% +39.92%
Gross Income
1.67B 1.98B 2.20B 2.75B
Gross Income Growth
+22.57% +18.23% +11.51% +24.68%
Gross Profit Margin
+29.91% +31.24% +30.97% +28.56%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.14B 1.27B 1.45B 1.99B
Research & Development
- - - -
-
Other SG&A
1.14B 1.27B 1.45B 1.99B
SGA Growth
+8.99% +10.85% +14.74% +36.96%
Other Operating Expense
- - - -
-
Unusual Expense
2.88M 91.75M 154.84M 117.56M
EBIT after Unusual Expense
526.58M 618.44M 596.21M 640.48M
Non Operating Income/Expense
52.17M 56.64M (12.54M) (19.38M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
23.05M 70.08M 175.45M 321.83M
Interest Expense Growth
-52.30% +204.07% +150.37% +83.43%
Gross Interest Expense
23.05M 70.08M 175.45M 321.83M
Interest Capitalized
- - - -
-
Pretax Income
555.70M 605.00M 408.23M 299.27M
Pretax Income Growth
+107.43% +8.87% -32.52% -26.69%
Pretax Margin
+9.95% +9.57% +5.74% +3.11%
Income Tax
150.12M 169.36M 94.39M 48.06M
Income Tax - Current - Domestic
62.87M 70.57M 90.03M 97.72M
Income Tax - Current - Foreign
112.98M 129.61M 126.07M 185.58M
Income Tax - Deferred - Domestic
(21.92M) (31.90M) (110.22M) (124.70M)
Income Tax - Deferred - Foreign
(3.81M) 1.07M (11.49M) (110.55M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
(5.79M) (6.63M) (6.00M) (9.50M)
Consolidated Net Income
399.79M 429.01M 307.84M 241.71M
Minority Interest Expense
- - - 591.00K
-
Net Income
399.79M 428.42M 307.84M 241.71M
Net Income Growth
+142.58% +7.16% -28.14% -21.48%
Net Margin Growth
+7.16% +6.77% +4.33% +2.51%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
399.79M 428.42M 307.84M 241.71M
Preferred Dividends
- - - -
-
Net Income Available to Common
399.79M 428.42M 307.84M 241.71M
EPS (Basic)
7.7849 8.3426 5.7218 3.72
EPS (Basic) Growth
+143.74% +7.16% -31.41% -34.99%
Basic Shares Outstanding
51.35M 51.35M 53.80M 64.98M
EPS (Diluted)
7.7022 8.2811 5.7001 3.7146
EPS (Diluted) Growth
+141.15% +7.52% -31.17% -34.83%
Diluted Shares Outstanding
51.91M 51.74M 54.01M 65.07M
EBITDA
806.63M 1.02B 1.14B 1.46B
EBITDA Growth
+36.16% +26.42% +11.73% +28.49%
EBITDA Margin
+14.44% +16.12% +16.01% +15.22%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 64.80
Number of Ratings 6 Current Quarters Estimate 2.897
FY Report Date 02 / 2026 Current Year's Estimate 12.253
Last Quarter’s Earnings 2.905 Median PE on CY Estimate N/A
Year Ago Earnings 11.373 Next Fiscal Year Estimate 13.976
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 5 2
Mean Estimate 2.90 2.95 12.25 13.98
High Estimates 3.01 2.96 13.04 14.03
Low Estimate 2.75 2.94 11.93 13.92
Coefficient of Variance 4.60 0.39 3.71 0.57

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 3
OVERWEIGHT 1 1 1
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Concentrix Corp - CNXC

Date Name Shares Transaction Value
Dec 4, 2025 Christopher A. Caldwell President and CEO; Director 280,586 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $36.52 per share 10,247,000.72
Dec 3, 2025 Cormac Twomey EVP, Global Ops & Delivery 35,130 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.5 per share 1,247,115.00
Apr 18, 2025 Olivier Fabrice Duha Director 292,360 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.08 per share 14,641,388.80
Apr 18, 2025 Olivier Fabrice Duha Director 280,721 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.19 per share 13,527,944.99
Apr 18, 2025 Olivier Fabrice Duha Director 292,588 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.46 per share 14,471,402.48
Apr 18, 2025 Olivier Fabrice Duha Director 299,042 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.24 per share 14,425,786.08
Apr 18, 2025 Olivier Fabrice Duha Director 9,499 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.21 per share 457,946.79
Apr 18, 2025 Olivier Fabrice Duha Director 16,675 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.42 per share 824,078.50
Apr 18, 2025 Olivier Fabrice Duha Director 23,568 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.3 per share 1,138,334.40
Apr 18, 2025 Olivier Fabrice Duha Director 1,144,350 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.2 per share 55,157,670.00
Apr 18, 2025 Olivier Fabrice Duha Director 1,155,862 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.45 per share 57,157,375.90
Apr 18, 2025 Olivier Fabrice Duha Director 1,162,570 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.25 per share 56,094,002.50
Mar 28, 2025 Ann F. Vezina Director 11,947 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Kathryn V. Marinello Director 10,003 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Nicolas Joseph Michel Gheysens Director 7,826 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Kathryn J. Hayley Director 10,011 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Jennifer Deason Director 10,003 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Te Chien Chou Director 306 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 LaVerne H. Council Director 10,003 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Dennis J. Polk Director 21,223 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Concentrix Corp in the News